ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways

No abstract is available for this paper.

• Publication year

  2026

• Venue

  bioRxiv

• Publication date

  2026-02-08

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.64898/2026.02.05.704041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of ADAM17 in smooth muscle cells enhances their transformation to macrophage-like cells leading to more severe atherosclerosis in mice.

  2025cited by this paper
• ADAM17 as a promising therapeutic target: from structural basis to inhibitor discovery in human diseases

  2025cited by this paper
• EXPRESIÓN DE ADAM17 Y NIVELES DE PTH SÉRICA EN PACIENTES CON Y SIN DIABETES EN DIÁLISIS: POSIBLES IMPLICACIONES EN LA CALCIFICACIÓN VASCULAR

  2025cited by this paper
• Involvement of ADAM17-Klotho Crosstalk in High Glucose-Induced Alterations of Podocyte Function

  2025cited by this paper
• An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies.

  2024cited by this paper
• SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin

  2023cited by this paper
• Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution

  2021cited by this paper
• Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes

  2021cited by this paper
• Redefining the Role of ADAM17 in Renal Proximal Tubular Cells and Its Implications in an Obese Mouse Model of Pre-Diabetes

  2021cited by this paper
• Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy

  2021cited by this paper
• MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

  2021cited by this paper
• The future of diabetic kidney disease management: what to expect from the experimental studies?

  2020cited by this paper
• Galectin-3 Modulates Macrophage Activation and Contributes Smooth Muscle Cells Apoptosis in Abdominal Aortic Aneurysm Pathogenesis

  2020cited by this paper
• Disease

  2020cited by this paper
• Kidney disease

  2019cited by this paper
• Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition

  2019cited by this paper
• SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis

  2018cited by this paper
• Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy

  2018cited by this paper
• Cancer and inflammation

  2017cited by this paper
• Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.

  2016cited by this paper
• Renal endothelial protein C receptor expression and shedding during diabetic nephropathy

  2016cited by this paper
• High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells*

  2015cited by this paper
• Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse

  2014cited by this paper
• Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults.

  2013cited by this paper
• ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.

  2013cited by this paper
• Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

  2012cited by this paper
• Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.

  2010cited by this paper
• Insulin stimulates Akt translocation to mitochondria: implications on dysregulation of mitochondrial oxidative phosphorylation in diabetic myocardium.

  2009cited by this paper
• [Therapeutic targets].

  2009cited by this paper
• possibilities

  2008cited by this paper
• A Role for galectin‐3 in renal tissue damage triggered by ischemia and reperfusion injury

  2008cited by this paper
• Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

  2008cited by this paper
• Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

  2004cited by this paper
• Autoimmunity

  1965cited by this paper

• No citing papers are available for this paper.